Yonhap Infomax NewsAug 5, 2025
SK Biopharmaceuticals delivers a surprise with Q2 operating profit soaring 137% to 61.8 billion won, signaling robust growth momentum in South Korea's biopharma sector.
#YonhapInfomax #SKBiopharmaceuticals #OperatingProfit #Q2Earnings #SurpriseResults #GrowthMomentum #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=75528
SK Biopharmaceuticals Posts 137% Surge in Q2 Operating Profit to 61.8 Billion Won in Surprise Earnings

SK Biopharmaceuticals delivers a surprise with Q2 operating profit soaring 137% to 61.8 billion won, signaling robust growth momentum in South Korea's biopharma sector.

Yonhap Infomax